开发一种强效和选择性的G2A (GPR132) 激进剂
Victor Hernandez-Olmos1,2, Jan Heering1,2, Beatrice Marinescu3
1Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany.
研究人员发现了一种新的G2A激动剂T-10418,它是研究G蛋白结合受体G2A的强大和有选择性的工具. 这种化合物显示出开发针对神经病痛,白血病和炎症的治疗方法的希望.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- G 蛋白结合受体的受体.
背景情况:
- G蛋白结合受体G2A (G2A) 是神经病痛,急性髓性白血病和炎症的潜在治疗点.
- 对于强效,选择性和类似药物的G2A激动剂在研究和药物开发中的可用性存在重大差距.
研究的目的:
- 发现和描述新的G2A激动剂.
- 为了阐明新发现的G2A激动剂支架的结构-活性关系 (SAR).
- 开发一种强效和选择性的G2A激动剂,适合作为药理学工具.
主要方法:
- 系统地优化G2A激动剂支架的系统优化.
- 结构与活动关系 (SAR) 研究.
- 针对G蛋白结合受体的强度和选择性分析.
- 评估物理化学性质 (可溶性,代谢稳定性).
主要成果:
- 发现了一种新的G2A激动剂支架.
- 鉴定 (3-(pyridin-3-ylmethoxy) benzoyl) -d-phenylalanine (T-10418) 作为一个化合物.
- T-10418显示出比天然配体9-HODE更高的功效.
- T-10418在G蛋白结合受体中表现出高选择性.
- T-10418具有良好的溶解性和高代谢稳定性.
结论:
- T-10418是一种强效和选择性的G2A激动剂.
- 其有利的药理学特征使其成为研究G2A激活的绝佳工具.
- 这一发现为开发针对G2A的治疗提供了有价值的起点.
更多相关视频
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
09:03Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
GPCR Desensitization
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Activation and Inactivation of G Proteins
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
